EU regulator endorses use of Moderna’s Covid-19 vaccine in teens
EMA's safety committee said while common side effects in teenagers after vaccination were similar to those seen in older population, due to a smaller study size, the trial could not detect new uncommon side effects or estimate the risk of known ones such as myocarditis and pericarditis

Europe’s medicines regulator on Friday recommended approving the use of Moderna’s COVID-19 vaccine in 12- to 17-year olds, paving the way for it to become the second shot okayed for adolescent use in the bloc.

The use of the vaccine, branded Spikevax, will be the same in adolescents as in people above 18 years, the European Medicines Agency (EMA) said, adding the vaccine produced a comparable antibody response to that seen in 18- to 25-year olds.

Vaccinating children has been considered important for reaching herd immunity against the novel coronavirus and in the light of the highly contagious Delta variant. Moderna in May said its vaccine was found to be safe and effective in teens.

EMA’s safety committee said while common side effects in teenagers after vaccination were similar to those seen in older population, due to a smaller study size, the trial could not detect new uncommon side effects or estimate the risk of known ones such as myocarditis and pericarditis.
Axact

Axact

Vestibulum bibendum felis sit amet dolor auctor molestie. In dignissim eget nibh id dapibus. Fusce et suscipit orci. Aliquam sit amet urna lorem. Duis eu imperdiet nunc, non imperdiet libero.

Post A Comment:

0 comments:

We encourage all readers to share their views on our articles and blog posts. We are committed to maintaining a lively but civil forum for discussion, so we ask you to avoid personal attacks, and please keep your comments relevant and respectful.

Share your articles, stories or happenings around you with us. Email: info.heraldnigeria@gmail.com